The possible effect of assisted reproduction on first-trimester screening for trisomy 21 was examined by fetal nuchal translucency thickness (NT), maternal serum free β-human chorionic gonadotrophin (HCG) and pregnancy-associated plasma protein-A (PAPP-A). METHODS: Parameters were measured at 11-14 weeks in 411 singleton pregnancies achieved by controlled ovarian stimulation, including 220 that had undergone IVF. Results were compared with 1233 singleton pregnancies conceived spontaneously. RESULTS: In the IVF pregnancies, the median fetal NT was not significantly different from that in controls, whilst the median free β-HCG was significantly increased, and PAPP-A was significantly decreased. In the intracytoplasmic sperm injection group, fetal NT and free β-HCG values were not significantly different from those in controls, but PAPP-A was significantly decreased. In those pregnancies achieved by ovarian stimulation, neither fetal NT, free β-HCG nor PAPP-A were significantly different from the control group. CONCLUSIONS: In IVF pregnancies, screening for trisomy 21 by fetal NT, maternal serum free β-HCG and PAPP-A levels may be associated with a 1.2% higher false-positive rate than in natural conception.
Introduction
in total HCG and alpha-fetoprotein (AFP) from naturally conceived pregnancies (Muller et al., 1993) , another two Screening for chromosomal abnormalities in pregnancy can studies of 41 and 67 IVF pregnancies reported that the median be achieved effectively at 11-14 weeks gestation by a combinaserum HCG concentration was 1.52 multiples of the median tion of maternal age, and monitoring fetal nuchal translucency (MOM) and 1.29 MOM respectively (Heinonen et al., 1996 ; thickness (NT) and concentrations of maternal serum free Ribbert et al., 1996) . Similarly, a study of 151 IVF pregnancies β-human chorionic gonadotrophin (β-HCG) and pregnancyreported that concentrations of unconjugated oestriol were 6% associated plasma protein-A (PAPP-A). This method, which lower, total HCG 14% higher and free β-HCG 9% higher than can be carried out in One Stop Clinics for Assessment of Risk in normal pregnancies (Wald et al., 1999) . Another study of (OSCAR), has been shown to identify about 90% of cases of 1632 women who had ovulation induction, and 298 who had trisomies 21, 18 or 13, sex chromosome aneuploidies and IVF, found that total HCG was significantly increased (1.09 triploidy at a 5-6% screen positive rate (Nicolaides et al., MOM) and unconjugated oestriol was decreased (0.92 MOM) 1992; Snijders et al., 1998; Spencer et al., , 2000a (Barkai et al., 1996) . Similarly, others (Frishman et al., 1997 ) Tul et al., 1999 Krantz et al., 2000) . examined 69 women who had IVF reported that total HCG In pregnancies achieved with assisted reproduction techwas significantly increased (1.22 MOM) and unconjugated niques, the prevalence of fetal abnormalities is not higher than oestriol was decreased (0.90 MOM). in natural conceptions, except perhaps for sex chromosome In this study, the possible effect of assisted reproduction on aneuploidies (Koulischer et al., 1997) . However, there is first-trimester screening for trisomy 21 was examined by some evidence that second-trimester biochemical screening for monitoring fetal NT and concentrations of maternal serum free trisomy 21 in assisted reproduction pregnancies is associated β-HCG and PAPP-A. with higher false-positive results, than in naturally conceived pregnancies, because of an unexplained increase in maternal Materials and methods serum HCG concentration and a decrease in unconjugated oestriol (Maymon et al., 1999a) . Although one study of 138
The Fetal Medicine Centre offers screening for chromosomal abnormalities by a combination of maternal age, fetal NT and concentrations pregnancies achieved by IVF reported no significant difference of maternal serum free β-HCG and PAPP-A at 11-14 weeks of percentage of nulliparous women was lower than in those gestation . Fetal NT was measured by transabachieved by assisted reproduction (P Ͻ 0.0001); there were dominal ultrasound examination as the maximum vertical distance no other significant differences in demographic characteristics between the skin and subcutaneous tissues at the back of the neck in between the two groups (Table I) . a sagittal section of the fetus lying in the neutral position, by
In the assisted reproduction pregnancies, free β-HCG, sonographers who received The Fetal Medicine Foundation Certificate PAPP-A and NT all fitted a Gaussian distribution after log 10 of Competence in first-trimester scanning (Nicolaides et al., 1992;  transformation (Kolmogorov-Smirnov test, P Ͻ 0.001) as was Snijders et al., 1998) . Concentrations of free β-HCG and PAPP-A confirmed for unaffected pregnancies .
were measured using a KRYPTOR analyser (CIS UK, High Wycombe, Compared with the controls, in the IVF pregnancies the median Bucks, UK). This is a random continuous access immunoassay maternal serum free β-HCG concentration was significantly analyser, using time-resolved amplified cryptate emission technology (TRACE), which provided results within 20 min of sampling (Spencer increased (P ϭ 0.001) and that of PAPP-A was decreased et al. 1999).
(P ϭ 0.025), whilst in the ICSI-conceived pregnancies median Demographic data, ultrasound findings and the results of biochem-PAPP-A concentration was decreased (P ϭ 0.037), and in the ical testing were entered into a fetal database at the time of assessment, ovarian stimulation group there were no significant differences and from this information patient-specific risks were produced.
in either free β-HCG or PAP-A (Table II) .
Outcome follow-up data were obtained from the patients or their
In the control group, the false-positive rate at a 1 in 300 doctors. In this retrospective study a search was made of the database first-trimester risk cut-off was 7.0% in this age-biased populato identify all singleton pregnancies (one live fetus and one gestational tion. By comparison, in the IVF group the false-positive rate sac) achieved by assisted reproduction, which had first-trimester was 15.9% for a similar age distribution. When the differences screening. A series of spontaneously conceived control pregnancies in the IVF group were used to model the impact of assisted (three per case) matched for maternal age, ethnic origin and smoking conception on the false-positive rate when screening for trisomy status were similarly identified.
21 in the general population, the increased maternal serum free β-HCG and reduced PAPP-A was found to increase the
Statistical analysis
false-positive rate at a 1 in 300 risk cut-off by 1.2%.
All free β-HCG, PAPP-A and NT measurements were converted to
In the assisted reproduction group, there were six cases with MOM, derived from previous studies (Snijders et al., 1998; of unaffected pregnancies and gestational age calculated chromosomal defects (Table III) maternal serum free β-HCG and PAPP-A at 11-14 weeks
The performance of first-trimester screening for trisomy 21 using gestation is likely to lead to a higher false-positive rate than fetal NT and maternal serum biochemical markers in spontaneously conceived and IVF pregnancies was assessed using standard statistical in natural conceptions and in those where assisted reproduction modelling techniques (Royston and Thompson, 1997) . Population is confined to controlled ovarian stimulation. Consequently, in parameters for unaffected pregnancies and those affected by trisomy IVF and ICSI pregnancies the invasive diagnostic testing rate-21 from an earlier study were used. Using and therefore the risk of miscarriage-would be increased. MOMs) were then used to calculate likelihood ratios which were Concentrations of maternal serum free β-HCG in IVF then used together with the age-related risk for trisomy 21 in the first trimester (Snijders et al., 1999) , to calculate the expected detection pregnancies were about 15% higher than in naturally conceived and false-positive rate at a fixed cut-off, in a population with the pregnancies. This increase is similar to that reported in the maternal age distribution of pregnancies in England and Wales (Office second trimester both for free β-HCG [9% by Wald et al. of National Statistics, 1997 .
(1999)] and for total HCG [29% by Ribbert et al. (1996) ; 22% by Frishman et al. (1997) ; 14% by Wald et al. (1999) ]. In ICSI pregnancies, maternal serum HCG concentrations in the Results second trimester are not significantly different from normal, but AFP concentrations are reduced (Lam et al., 1999) . First-trimester assessment was carried out in 411 singleton pregnancies achieved after controlled ovarian stimulation, Similarly, we found that in the first trimester there was no significant change in concentrations of free β-HCG, but those including 220 that had undergone IVF and 30 that had undergone ICSI. In the naturally conceived pregnancies the of PAPP-A were reduced. Accurate risk estimates in IVF pregnancies undergoing firstreproduction to determine the effectiveness of screening with adjusted means. trimester screening for chromosomal defects requires correction of the measured concentrations to reduce the overestimate of Fetal NT was not affected by assisted reproduction, and this is in agreement with a previous study of 75 singleton risk. It was suggested previously that in IVF pregnancies undergoing second-trimester biochemical screening for chropregnancies achieved by assisted reproduction (Maymon et al., 1999b ). In the current study, NT screening alone mosomal defects the measured MOM should be divided by the median MOM obtained in IVF pregnancies (Wald et al., would have identified all six chromosomally abnormal fetuses. However, in a multicentre study of 96 127 pregnan-1999). This procedure was shown to bring the false-positive rate back to the rate observed in naturally conceived pregnancies.
Screening for trisomy 21 in assisted reproduction
cies, including 326 with trisomy 21, the sensitivity of screening by nuchal translucency was 77% for a falseCorrecting in a similar manner in the current first-trimester study would have also reduced the false-positive rate to that positive rate of 5% (Snijders et al., 1998) . Screening by a combination of nuchal translucency and first-trimester bioin the control group. However, before such adjustment of risk calculation is considered, it would be necessary to study a chemistry improves the detection of trisomy 21 to~90% (Spencer et al., , 2000d Krantz et al., 2000) . It would large number of trisomy 21 pregnancies achieved by assisted A.W.Liao et al. Neveux, L.M., Palomaki, G.E., Larivee, D.A. et al. (1996) 
